Teclistamab for relapsed refractory multiple myeloma patients on dialysis
Br J Haematol
.
2024 Nov;205(5):2077-2079.
doi: 10.1111/bjh.19772.
Epub 2024 Sep 14.
Authors
P Lebreton
1
,
F Lachenal
2
,
S Bouillie
3
,
G M Pica
4
,
H Aftisse
5
,
L Pascal
6
,
L Montes
7
,
M Macro
8
,
N Johnson
9
,
S Harel
10
,
M Fernandez
11
,
B De Renzis
12
,
B Lioure
13
,
A Lazareth
14
,
M Javelot
3
,
C Louni
15
,
A Huart
16
,
A Perrot
17
Affiliations
1
Hôpital Le Havre J Monod, Montivilliers, France.
2
Hôpital Nord Dauphiné, Bourgoin Jallieu, France.
3
J&J Innovative Medicine, Issy les Moulineaux, France.
4
Hôpital Chambéry, Chambéry, France.
5
Hôpital Saint Quentin, Saint-Quentin, France.
6
Hôpital Saint Vincent de Paul Lille, Lille, France.
7
CHU Amiens, Amiens, France.
8
CHU Caen, Caen, France.
9
Hôpital Cochin, Paris, France.
10
Hôpital Saint Louis, Paris, France.
11
J&J Innovative Medicine, Madrid, Spain.
12
CHU Clermont Ferrand, Clermont Ferrand, France.
13
ICANS, Strasbourg, France.
14
CHU Lyon, Lyon, France.
15
IFM Paris, Paris, France.
16
CHU Toulouse Rangueil, Toulouse, France.
17
Service d'Hématologie, CHU de Toulouse, IUCT Oncopole, Toulouse, France.
PMID:
39275880
DOI:
10.1111/bjh.19772
No abstract available
Publication types
Letter
Grants and funding
Intergroupe Francophone du Myélome (IFM) Group